Manufacturer record
Sharun Pharmaceuticals Pvt.Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Sharun Pharmaceuticals Pvt.Ltd (Puducherry) were declared Not of Standard Quality between January 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SP250935, Diclofenac Sodium Tablets IP 50mg (exp Aug 2027). Drugs Testing Laboratory, Chennai-06 (state lab) found it not of standard quality: Dissolution. Listed in the July 2026 alert.
Records by type
5 records linked to Sharun Pharmaceuticals Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Tablets IP 50mg | Batch SP250935Mfg Sep 2025 · Exp Aug 2027 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Diclofenac Sodium Tablets IP 50mg | Batch SP250934Mfg Sep 2025 · Exp Aug 2027 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Albendazole Tablets IP 400 mg | Batch SP250907Mfg Sep 2025 · Exp Aug 2027 | Uniformity of WeightUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Albendazole Tablets IP 400mg | Batch SP250725Mfg Jul 2025 · Exp Jun 2027 | DissolutionDissolution | DTL, Chennai-06State lab | Feb 2026 |
| Paracetamo l, Phenylephri ne HCl, Caffeine & Diphenhydr amine HCl Tablets (CINKOLD) | Batch SG034B0 3Mfg Feb 2023 · Exp Jan 2025 | NOTE:(i) On the received sample, Presence of Spot defect was observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration. (ii)The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. vel - NSQLabelling | State Lab PuducherryState lab | Jan 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.